Health Care Equipment

LogicMark

LogicMark released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 2.915 M (forecast USD 2.722 M), actual EPS USD -2.213 (forecast USD 0)

LogicMark released FY2025 9 Months Earnings on November 13 (EST), actual revenue USD 8.36 M, actual EPS USD -98.6161

LogicMark released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 2.853 M (forecast USD 2.348 M), actual EPS USD -2.9026 (forecast USD -22.5005)

LogicMark released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 5.445 M, actual EPS USD -11.6041

LogicMark to Release FY2025 Q2 Earnings on August 12 After-Market EST, Forecast Revenue USD 2.348 M, EPS USD -0.03

LogicMark Inc. Extends CEO Contract to 2026

LogicMark Inc Reports Q1 EPS Loss of 12 Cents with Revenue Decline

LogicMark released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 2.592 M (forecast USD 2.627 M), actual EPS USD -93.5005 (forecast USD -22.5005)

LogicMark Reports Q3 2024 Earnings, Revenue Down but New Product Launched

LogicMark Inc Reports Quarterly Financial Results for the Quarter Ending December 31

LogicMark released FY2024 Annual Earnings on March 31, 2025 (EST), actual revenue USD 9.902 M (forecast USD 9.885 M), actual EPS USD 0 (forecast USD -1.628 K)

LogicMark released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 2.249 M (forecast USD 2.232 M), actual EPS USD 0 (forecast USD -885.0221)

LogicMark Inc Receives Notification of Non-Compliance with Nasdaq Minimum Bid Requirements

LogicMark released FY2024 9 Months Earnings on November 13 (EST), actual revenue USD 7.653M, actual EPS USD 0

LogicMark released FY2024 Q3 earnings on November 13 (EST), actual revenue USD 2.705 M (forecast USD 2.438 M), actual EPS USD 0 (forecast USD -8.063 K)

LogicMark to Release FY2024 Q3 Earnings on November 12 After-Market EST, Forecasted Revenue 2.438 M USD, EPS -10.75 USD

LogicMark released FY2024 Semi-Annual earnings on August 14 (EST), actual revenue USD 4.947 M, actual EPS USD 0

LogicMark released FY2024 Q2 earnings on August 13 After-Market (EST), actual revenue USD 2.336 M (forecast USD 2.374 M), actual EPS USD -24.1225 (forecast USD -26.75)

LogicMark released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 2.611 M (forecast USD 2.838 M), actual EPS USD 0 (forecast USD -22)

LogicMark released FY2023 Q4 earnings on April 16 (EST), actual revenue USD 2.426 M (forecast USD 2.28 M), actual EPS USD 0 (forecast USD -43.25)

Sobr Safe

Omeros

Northann

AMC Robotics

Euda Health

Dynavax Tech

Multi Ways

Indaptus Therapeutics

Sidus Space

Kandal M Venture

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap